In vitro functional effects of XPC gene rare variants from bladder cancer patients

Carcinogenesis

Volumn 32, Issue 4, 2011, Pages 516-521

  Qiao, Boling ^a   Ansari, Abdul Haq ^a   Scott, Gina B ^a   Sak, Sei C ^a   Chambers, Philip A ^a   Elliott, Faye ^a   Teo, Mark T W ^a   Bentley, Johanne ^a   Churchman, Michael ^a   Hall, Janet ^b,c   Taylor, Claire F ^a   Bishop, Timothy D ^a   Knowles, Margaret A ^a   Kiltie, Anne E ^a,d  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b INSERM U612   (France)

^c INSTITUT CURIE   (France)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MESSENGER RNA; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

3' UNTRANSLATED REGION; AGED; ALGORITHM; AMINO ACID SUBSTITUTION; ARTICLE; BLADDER CANCER; CANCER PATIENT; CASE CONTROL STUDY; CONTROLLED STUDY; DNA DAMAGE; EXON; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LASER MICROBEAM MICRODISSECTION; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PLASMID; PRIORITY JOURNAL; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTRAL SENSITIVITY;

3' UNTRANSLATED REGIONS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; URINARY BLADDER NEOPLASMS;

EID: 79953706289     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr005     Document Type: Article

References (42)

1. Jemal,A. et al. (2008) Cancer statistics, 2008. CA Cancer J. Clin., 58, 71-96.
2. Friedberg,E.C. (2001) How nucleotide excision repair protects against cancer. Nat. Rev. Cancer, 1, 22-33.
3. van Steeg,H. et al. (1999) Xeroderma pigmentosum and the role of UVinduced DNA damage in skin cancer. Mol. Med. Today, 5, 86-94.
4. Masutani,C. et al. (1994) Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J., 13, 1831-1843.
5. Yasuda,G. et al. (2007) In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation. Mol. Cell. Biol., 27, 6606-6614.
6. Sugasawa,K. et al. (1998) Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell, 2, 223-232.
7. Kraemer,K.H. et al. (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch. Dermatol., 123, 241-250.
8. Swift,M. et al. (1979) Cancer in families with xeroderma pigmentosum. J. Natl Cancer Inst., 62, 1415-1421.
9. Olsen,J.H. et al. (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J. Natl Cancer Inst., 93, 121-127.
10. Gruber,S.B. et al. (2002) BLM heterozygosity and the risk of colorectal cancer. Science, 297, 2013.
11. Friedberg,E.C. et al. (2000) Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat. Res., 459, 99-108.
12. Hollander,M.C. et al. (2005) Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc. Natl Acad. Sci. USA, 102, 13200-13205.
13. Melis,J.P. et al. (2008) Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res., 68, 1347-1353.
14. Kuraoka,I. et al. (2000) Removal of oxygen free-radical-induced 5',8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl Acad. Sci. USA, 97, 3832-3837.
15. D'Errico,M. et al. (2006) New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J., 25, 4305-4315.
16. Shimizu,Y. et al. (2003) Xeroderma pigmentosum group C protein interacts physically and functionally with thymine DNA glycosylase. EMBO J., 22, 164-173.
17. Sak,S.C. et al. (2006) Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 2537-2541.
18. Sak,S.C. et al. (2005) The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br. J. Cancer, 92, 2262-2265.
19. Hughes,T.A. et al. (2005) Cross-talk between pRb/E2F and Wnt/betacatenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death. Exp. Cell Res., 303, 32-46.
20. Godon,C. et al. (2008) PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility. Nucleic Acids Res., 36, 4454-4464.
21. Giglia,G. et al. (1998) p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res., 58, 4402-4409.
22. Knowles,M.A. (2008) Molecular pathogenesis of bladder cancer. Int. J. Clin. Oncol., 13, 287-297.
23. Takebayashi,Y. et al. (2001) Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors. Cancer Lett., 174, 115-125.
24. Okuda,Y. et al. (2004) Relative levels of the two mammalian Rad23 homologs determine composition and stability of the xeroderma pigmentosum group C protein complex. DNA Repair (Amst.), 3, 1285-1295.
25. Boffa,M.B. et al. (2008) Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis. Blood, 111, 183-189.
26. Wang,J. et al. (2006) 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. Biochem. Biophys. Res. Commun., 340, 491-497.
27. Kamiyama,M. et al. (2007) Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Hum. Genet., 122, 397-407.
28. Khan,S.G. et al. (2004) Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum. Mol. Genet., 13, 343-352.
29. Chavanne,F. et al. (2000) Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res., 60, 1974-1982.
30. Bernardes de Jesus,B.M. et al. (2008) Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC. Mol. Cell. Biol., 28, 7225-7235.
31. Bunick,C.G. et al. (2006) Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein. Biochemistry, 45, 14965-14979.
32. Khan,S.G. et al. (2006) Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis, 27, 84-94.
33. Matakidou,A. et al. (2006) Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition. Int. J. Cancer, 119, 964-967.
34. Hoogervorst,E.M. et al. (2004) p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice. Cancer Res., 64, 5118-5126.
35. Bodmer,W. et al. (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet., 40, 695-701.
36. Fearnhead,N.S. et al. (2004) Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc. Natl Acad. Sci. USA, 101, 15992-15997.
37. Tenesa,A. et al. (2006) Association of MUTYH and colorectal cancer. Br. J. Cancer, 95, 239-242.
38. Clarkson,S.G. et al. (2005) Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst.), 4, 1068-1074.
39. Hoogervorst,E.M. et al. (2005) 2-AAF-induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repair. DNA Repair (Amst.), 4, 3-9.
40. Topol,E.J. et al. (2007) The resequencing imperative. Nat. Genet., 39, 439-440.
41. Johnson,D.S. et al. (2007) Genome-wide mapping of in vivo protein-DNA interactions. Science, 316, 1497-1502.
42. Barski,A. et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell, 129, 823-837.